These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Interaction of genetic and exposure factors in the prevalence of berylliosis. Richeldi L; Kreiss K; Mroz MM; Zhen B; Tartoni P; Saltini C Am J Ind Med; 1997 Oct; 32(4):337-40. PubMed ID: 9258386 [TBL] [Abstract][Full Text] [Related]
44. Crystal structure of HLA-DP2 and implications for chronic beryllium disease. Dai S; Murphy GA; Crawford F; Mack DG; Falta MT; Marrack P; Kappler JW; Fontenot AP Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7425-30. PubMed ID: 20356827 [TBL] [Abstract][Full Text] [Related]
45. Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity. Rossman MD; Stubbs J; Lee CW; Argyris E; Magira E; Monos D Am J Respir Crit Care Med; 2002 Mar; 165(6):788-94. PubMed ID: 11897645 [TBL] [Abstract][Full Text] [Related]
46. Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease. Falta MT; Pinilla C; Mack DG; Tinega AN; Crawford F; Giulianotti M; Santos R; Clayton GM; Wang Y; Zhang X; Maier LA; Marrack P; Kappler JW; Fontenot AP J Exp Med; 2013 Jul; 210(7):1403-18. PubMed ID: 23797096 [TBL] [Abstract][Full Text] [Related]
47. Regulatory T cells modulate granulomatous inflammation in an HLA-DP2 transgenic murine model of beryllium-induced disease. Mack DG; Falta MT; McKee AS; Martin AK; Simonian PL; Crawford F; Gordon T; Mercer RR; Hoover MD; Marrack P; Kappler JW; Tuder RM; Fontenot AP Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8553-8. PubMed ID: 24912188 [TBL] [Abstract][Full Text] [Related]
48. Racial differences in prevalence of a supratypic HLA-genetic marker immaterial to pre-employment testing for susceptibility to chronic beryllium disease. Weston A; Ensey J; Kreiss K; Keshava C; McCanlies E Am J Ind Med; 2002 Jun; 41(6):457-65. PubMed ID: 12173370 [TBL] [Abstract][Full Text] [Related]
49. Association between IL-1A single nucleotide polymorphisms and chronic beryllium disease and beryllium sensitization. McCanlies EC; Yucesoy B; Mnatsakanova A; Slaven JE; Andrew M; Frye BL; Schuler CR; Kreiss K; Weston A J Occup Environ Med; 2010 Jul; 52(7):680-4. PubMed ID: 20595916 [TBL] [Abstract][Full Text] [Related]
50. Immunologic Effects of Beryllium Exposure. Fontenot AP Ann Am Thorac Soc; 2018 Apr; 15(Suppl 2):S81-S85. PubMed ID: 29676647 [TBL] [Abstract][Full Text] [Related]
51. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta. Bost TW; Riches DW; Schumacher B; Carré PC; Khan TZ; Martinez JA; Newman LS Am J Respir Cell Mol Biol; 1994 May; 10(5):506-13. PubMed ID: 8179912 [TBL] [Abstract][Full Text] [Related]